Adherex Technologies Q4 Earnings Call Highlights

Fennec Pharmaceuticals reported grounds commercialized maturation for PEDMARK during its 4th fourth and afloat twelvemonth 2025 net call, highlighting expanding adoption successful some caller and existing accounts, improved diligent enactment metrics, and steps to broaden objective grounds supporting the drug’s usage beyond its pivotal program.

Chief Executive Officer Jeff Hackman said 2025 was a “transformational year” for the company, driven by quarter-over-quarter maturation successful progressive patients arsenic good arsenic caller and existing accounts. Fennec posted record nett merchandise income of $44.6 cardinal for 2025, up from $29.6 cardinal successful 2024, and fourth-quarter nett merchandise income of $13.8 million, up from $7.9 cardinal successful the prior-year quarter.

→ Planet Labs: The Satellite Stock That Keeps Shooting to the Moon

Chief Financial Officer Robert Andrade noted that fourth-quarter results marked the fifth consecutive 4th of nett merchandise income growth. He attributed the year-over-year summation to broader maturation crossed accounts and “notable occurrence and progress” successful conversion and adherence among PEDMARK patients.

Hackman said the institution made a strategical determination successful the 4th fourth to increase its customer-facing team to amended scope and telephone frequency, including added absorption connected caller territories and “high-prescribing targets” successful the teen and young big (AYA) market.

→ Active ETFs Surge Past Passive, and These Are successful the Lead

Hackman emphasized the show of the company’s full-service diligent enactment program, Fennec HEARS, which provides sum and reimbursement navigation, escaped merchandise for eligible individuals, and coordination of nurse-led medication and at-home infusion services. He said the programme delivered grounds show successful the 4th fourth with all-time highs successful diligent enrollments, prescribed and infused vials, progressive patients, and conversion rates.

Management said conversion rates improved implicit the people of the year, citing an summation from 50% successful the archetypal 4th to 70% successful the 4th quarter. Hackman said these results bespeak some diligent request and execution by the tract enactment and operational infrastructure.

→ Trash to Treasure: 3 Waste Removal Stocks to Minimize Volatility

On the selling front, Hackman said the institution is expanding efforts to activate young big testicular crab patients and plans to motorboat an inaugural tied to the Indy 500 successful May successful concern with a testicular crab advocacy group. He besides said Fennec expects a important beingness astatine the ASCO gathering successful Chicago aboriginal this year.